JP5331116B2 - 粒子放射線で増強された治療を供給するシステム及び方法 - Google Patents

粒子放射線で増強された治療を供給するシステム及び方法 Download PDF

Info

Publication number
JP5331116B2
JP5331116B2 JP2010520162A JP2010520162A JP5331116B2 JP 5331116 B2 JP5331116 B2 JP 5331116B2 JP 2010520162 A JP2010520162 A JP 2010520162A JP 2010520162 A JP2010520162 A JP 2010520162A JP 5331116 B2 JP5331116 B2 JP 5331116B2
Authority
JP
Japan
Prior art keywords
agent
delivery vehicle
intracorporeal
internal
nanostructure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010520162A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010535084A5 (https=
JP2010535084A (ja
Inventor
ラインハルト シュルテ
ギルマー ヴァルデス−ディアス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Loma Linda University
Original Assignee
Loma Linda University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loma Linda University filed Critical Loma Linda University
Publication of JP2010535084A publication Critical patent/JP2010535084A/ja
Publication of JP2010535084A5 publication Critical patent/JP2010535084A5/ja
Application granted granted Critical
Publication of JP5331116B2 publication Critical patent/JP5331116B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1087Ions; Protons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1098Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
JP2010520162A 2007-07-30 2008-07-30 粒子放射線で増強された治療を供給するシステム及び方法 Expired - Fee Related JP5331116B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95277307P 2007-07-30 2007-07-30
US60/952,773 2007-07-30
PCT/US2008/071653 WO2009018383A1 (en) 2007-07-30 2008-07-30 Systems and methods for particle radiation enhanced delivery of therapy

Publications (3)

Publication Number Publication Date
JP2010535084A JP2010535084A (ja) 2010-11-18
JP2010535084A5 JP2010535084A5 (https=) 2013-04-25
JP5331116B2 true JP5331116B2 (ja) 2013-10-30

Family

ID=40304856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010520162A Expired - Fee Related JP5331116B2 (ja) 2007-07-30 2008-07-30 粒子放射線で増強された治療を供給するシステム及び方法

Country Status (5)

Country Link
EP (1) EP2173430A4 (https=)
JP (1) JP5331116B2 (https=)
AU (1) AU2008282215B2 (https=)
CA (1) CA2695985C (https=)
WO (1) WO2009018383A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3136594B2 (ja) 1990-02-28 2001-02-19 ソニー株式会社 非水電解液二次電池

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669533B2 (en) 2009-10-01 2014-03-11 Vladimir Bashkirov Ion induced impact ionization detector and uses thereof
JP2023512214A (ja) 2020-01-28 2023-03-24 リフレクション メディカル, インコーポレイテッド 放射性核種および外部ビーム放射線療法の共同最適化

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870287A (en) 1988-03-03 1989-09-26 Loma Linda University Medical Center Multi-station proton beam therapy system
US4917344A (en) 1988-04-07 1990-04-17 Loma Linda University Medical Center Roller-supported, modular, isocentric gantry and method of assembly
US5117829A (en) 1989-03-31 1992-06-02 Loma Linda University Medical Center Patient alignment system and procedure for radiation treatment
GB9020075D0 (en) * 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US5825845A (en) 1996-10-28 1998-10-20 Loma Linda University Medical Center Proton beam digital imaging system
US6645464B1 (en) * 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US20050090732A1 (en) * 2003-10-28 2005-04-28 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
RU2006144851A (ru) * 2004-06-15 2008-06-20 Бакстер Интернэшнл Инк. (Us) Применение терапевтических средств ex-vivo в виде твердых микрочастиц
US20070009441A1 (en) * 2004-07-08 2007-01-11 Molecular Therapeutics, Inc. Biodegradable nanoparticles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3136594B2 (ja) 1990-02-28 2001-02-19 ソニー株式会社 非水電解液二次電池

Also Published As

Publication number Publication date
CA2695985A1 (en) 2009-02-05
AU2008282215A1 (en) 2009-02-05
EP2173430A1 (en) 2010-04-14
JP2010535084A (ja) 2010-11-18
AU2008282215B2 (en) 2014-05-29
CA2695985C (en) 2016-06-28
WO2009018383A1 (en) 2009-02-05
EP2173430A4 (en) 2012-11-21

Similar Documents

Publication Publication Date Title
Chua et al. Emerging technologies for local cancer treatment
Chen et al. Gold nanoparticles as radiosensitizers in cancer radiotherapy
Bilynsky et al. Radiation nanosensitizers in cancer therapy—From preclinical discoveries to the outcomes of early clinical trials
Kuncic et al. Nanoparticle radio-enhancement: principles, progress and application to cancer treatment
Rancoule et al. Nanoparticles in radiation oncology: From bench-side to bedside
Lacombe et al. Particle therapy and nanomedicine: state of art and research perspectives
Babu et al. Nanoparticle‐based drug delivery for therapy of lung cancer: progress and challenges
US20150050349A1 (en) Systems and methods for particle radiation enhanced delivery of therapy
Chatterjee et al. Convergence of nanotechnology with radiation therapy—insights and implications for clinical translation
Ghosh et al. Cancer brachytherapy at the nanoscale: an emerging paradigm
Eblan et al. Improving chemoradiotherapy with nanoparticle therapeutics
JP6905051B2 (ja) イオン注入により形成された中性子捕捉療法用の組成物
US20050259787A1 (en) System and method for monochromatic x-ray beam therapy
Sah et al. Effect of size on gold nanoparticles in radiation therapy: Uptake and survival effects
Mukherjee et al. Recent update on nanocarrier (s) as the targeted therapy for breast cancer
JP5331116B2 (ja) 粒子放射線で増強された治療を供給するシステム及び方法
Edward Werner et al. Chemoradiotherapy of human tumors: novel approaches from nanomedicine
Bhandari et al. Recent innovations in nanomedicine and nano-based techniques for the treatment of breast cancer
EP3180085B1 (en) Means and methods for targeted x-ray therapy
Singh et al. Nano-oncology: clinical application for cancer therapy and future perspectives
JP2010535084A5 (https=)
Khalaji et al. Recent developments in nanoparticle-enhanced radiotherapy for breast cancer treatment
Anuje et al. Radiotherapy and breast cancer nanomedicine
Zaheer Cancer Nanomedicines in the Clinic: Coming of Age
Tng et al. Nanoparticles for Enhanced Radiotherapy and Imaging Applications

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121211

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121213

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20130116

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20130308

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130702

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130726

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees